Abstract: Use of a at least one type of xanthophylls for the preparation of a medicament for prophylactic and/or therapeutic treatment of dyspepsia, is disclosed. The xanthophyll is preferably astaxanthin, e.g. astaxanthin is in a form esterified with fatty acids, such as in algal meal prepared from a culture of the alga Haematococcus sp. The medicament may further comprise carbohydrate structures and/or (a) different antioxidant(s). Further, a method of prophylactic and/or therapeutic treatment of dyspepsia in an individual, is described. The method comprises administration to said individual of an dyspepsia-alleviating amount of a medicament comprising at least one type of xanthophylls.
Abstract: This invention relates to a medicine combination used to treat headache, which is made up of Chuanxiong and Tianma in a certain scientific weight proportion. The medicine combination can be made into any commonly used dosage form. The invention also provides other applications of this medicine combination in the production of an anti-oxidative drug, an antihypertensive drug, a platelet antiaggregation drug, an antithrombosis drug and an anticoagulant.
Abstract: It is an object of the present invention to provide immunopotentiators and immunotherapeutic formulations available at low cost and having a benign side effect profile. According to the present invention, an LAK activity enhancer containing an extract of Lentinus edodes mycelium and an LAK activity-enhancing formulation containing said enhancer are provided.
Abstract: Described is a composition for the prevention and treatment of symptoms associated with ethyl alcohol consumption. The composition comprises silymarin, salicin, at least one B vitamin, magnesium, molybdenum and manganese. Treatment of symptoms associated with the consumption of ethyl alcohol involves ingesting the described composition prior to, during, or after the consumption of the alcohol.
Abstract: The present invention relates to a method for utilizing soy molasses as a source for soy sugars which are of high oligosaccharaide content. The invention provides a method for purifying soy molasses comprising the following steps: (i) contacting the soy molasses with alcohol and hydrocarbon solvent mixture, thereby two layers comprising a lower aqueous-alcohol layer and an upper hydrocarbon layer are formed; (ii) collecting the lower aqueous-alcohol layer; (iii) removing coloring, off-flavor and odorous substances; and (iv) removing minerals, thereby a purified soy molasses of more than 90 wt. % sugars, on dry matter basis, is obtained.
Abstract: A method of cosmetically repairing a skin contour irregularity in a subject is provided. The method is effected by introducing cartilage producing cells into the skin contour irregularity thereby effecting cosmetic repair thereof. A medical implant coated with cartilage producing cells is further disclosed.
Abstract: The present invention provides a method for processing defatted oil seeds, comprising the steps of: (a) solubilizing at least a portion of the protein contained in the oil seeds to produce suspended residual solids and a first solution comprising protein, phenolic-protein complexes, and free phenolic compounds; (b) separating at least a portion of the free phenolic compounds from the first solution and recovering a free phenolic reduced solution; and (c) treating the free phenolic reduced solution to precipitate at least a portion of the protein as a precipitated protein isolate and recovering a treated solution containing a soluble protein isolate. Novel protein products are also disclosed. Food and drink products containing the novel protein products are also disclosed.
Type:
Grant
Filed:
May 28, 2002
Date of Patent:
June 14, 2005
Inventors:
Levente Laszlo Diosady, Lei Xu, Bih-King Chen
Abstract: A method for preparing a Bowman-Birk inhibitor (BBI) product from soybeans is provided. The product produced in accordance with the method of the invention and compositions including the product are also provided. BBI product produced in accordance with the invention is a significantly improved inhibiter of malignant cell transformation and methods for its administration to prevent or inhibit progression of cancer are provided.
Abstract: An anti-inflammatory agent exhibiting an anti-inflammatory function is provided, which includes either a set of dried substances or an extract of Perilla leaf, Cacao and Fennel, and preferably Perilla leaf, Cacao, Fennel, Fenugreek seed, Rosemary, Juniper berry and Celery seed. This specific set or combination of those natural herbs is effective to relax and suppress symptoms of allergy, particularly holistic symptoms of allergic rhinitis, without causing any substantive adverse effects. Since all of the ingredients included in agent are derived from the natural herbs, a long-term administration of the agent may cause substantively no adverse effects. Also, inclusion of the agent into foods and drinks is also useful.
Abstract: An Echinacea angustifolia extract and a process for the preparation thereof are herein described. The extract is characterized by an alkylamides content lower than 0.1%, an echinacoside content ranging from 1 to 10% and containing from 1 to 15% of a polysaccharide characteristic of Echinacea angustifolia. The extract can be used for the treatment of pathological conditions in which it is desirable to strengthen the immune defenses.
Type:
Grant
Filed:
November 25, 2002
Date of Patent:
April 19, 2005
Assignee:
Indena S.p.A.
Inventors:
Andrea Giori, Alessandro Anelli, Paolo Morazzoni, Francesco Di Pierro
Abstract: The present invention relates to an antioxidant composition and a method of preparation thereof. In detail, the present invention relates to an antioxidant composition containing procyanidin B3 obtained from Rosa multiflora, and a preparation method for the antioxidant composition, comprising extraction of the underground part of Rosa multiflora with an organic solvent, followed by fractionation and purification of the extract by chromatography. The antioxidant composition of the present invention can be effectively used in treatment or prevention of various diseases due to oxidation by reactive oxygen species, maintenance of quality of food, and prevention of skin damages due to oxidation.
Type:
Grant
Filed:
November 7, 2002
Date of Patent:
February 22, 2005
Assignee:
Eromlife Co. Ltd.
Inventors:
Mi-Hyoun Park, Nam-In Baek, Jae-Taek Han, Chang-Won Choi
Abstract: The present invention relates to a novel method useful for fast separation and quick identification of active ingredients in herbs. The separation procedures are efficient without tedious and time-consuming works by using chromatographies or HPLC. The present invention further relates to a method for ascertaining the quality of herbs by applying treated plastic slides on quality control of herbal fractions, based on identification of their biological activities.
Abstract: The invention is a composition and a method for agriculture. The composition is a semisynthetic mixture (a) which includes (1) an organic compound which is essentially emitted in the fermentation of vegetable parts of the palm tree or related plant, (2) a vegetable material obtained from the palm tree or related plant and which has been ground, fermented, and stabilized, and (3) an organic compound emitted in minor quantity during the fermentation of the vegetable parts of the palm tree or related plant; and (b) a pheromone which is appropriate to control for the target insect. The method includes the application of the composition to a plantation of palm trees and related plants to be protected.
Type:
Grant
Filed:
September 4, 1998
Date of Patent:
February 8, 2005
Assignee:
Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)
Inventors:
José Rafael Esteban Duran, José Luis Tadeo Lluch, Francisco Beitia Crespo, Antonio Jimenez Alvarez, Consuelo Sanchez-Brunete Palop
Abstract: Materials which are not themselves storage-stable at room temperature are made suitable for storage by mixing them with a carrier substance and spray drying the resulting mixture so as to form particles containing both the material and the carrier substance in which the carrier substance is in an amorphous, i.e. glassy or rubbery, state. Formation of such a composition greatly enhances stability. The material stored may be a biological material such as an enzyme, the components of a chemical reaction such as reagents for carrying out an assay, or even viable biological cells.
Type:
Grant
Filed:
February 8, 2002
Date of Patent:
November 30, 2004
Assignee:
Nektar Therapeutics
Inventors:
Felix Franks, Ross Henry Hatley, Sheila Frances Mathias
Abstract: The invention discloses a pharmaceutical composition for preventing and/or treating peptic ulcer, including American ginseng or the extract thereof, and a method for preparing American ginseng extract, said method including extracting American ginseng with water or ethanol aqueous solution, and then ultrafiltrating, dialyzing, precipitating with ethanol, or performing reverse phase chromatography to obtain various fractions of extract with anti-peptic ulcer effect.
Type:
Grant
Filed:
May 6, 2002
Date of Patent:
October 5, 2004
Assignee:
Pharmaceutical Industry Technology and Development
Center
Abstract: A process to obtain a highly soluble, low viscosity, salt tolerant gelling vegetable protein product. When introduced into a suitable meat injection brine, the protein product is capable of forming a firm sliceable meat piece with high water retention and no visible signs of the injected brine. When included in gel-based food products such as meat analog formulas, the protein product is capable of forming the desired gel structure, such as firm, sliceable meat-like pieces.
Type:
Grant
Filed:
January 15, 2002
Date of Patent:
September 28, 2004
Assignee:
Solae, LLC
Inventors:
Charles W. Monagle, Helge S. Pedersen, Carmen M. Darland, Navpreet Singh
Abstract: Phytopharmaceutical food products which contain plant extracts and aminoacids and which can be used in order to reduce tobacco smoke addiction.
Abstract: A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in ‘mucosal delivery format’: a dosage form that promotes effective absorption through the lining of the oral cavity.
Abstract: The use of at least one type of xanthophylls for the production of a medicament for suppression of excessive Th1 cell mediated immune responses and stimulation of Th2 cell mediated immune responses in a patient during ongoing infection and/or inflammation in said patient is disclosed. Excessive Th1 cell mediated immune responses are caused by such autoimmune diseases and chronic viral and intracellular bacterial infections as Psoriasis vulgaris, Multiple sclerosis (MS), Rheumatoid arthritis, Crohn's disease, insulin-dependent diabetes mellitus, Tuberculosis (TB), Acute graft-versus-host disease (transplant rejection) and HIV virus infection. The preferred type of xanthophyll is astaxanthin, particularly in a form esterified with fatty acids, obtainable by for example culturing the algae Haematococcus sp.